20 LATEST RESOURCES (174 INDEXED)
Impacts of Metabolic Disruption, Body Mass Index and Inflammation on Cognitive Function in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine · February 2024
Articles
Annals of General Psychiatry
The Real-World Effectiveness of Fluvoxamine Therapy in Mild to Moderate COVID-19 Patients; A Historical Cohort Study (Fluvoxa Trial) · October 2023
Articles
Journal of Infection and Public Health
Trends in Delirium and New Antipsychotic and Benzodiazepine Use among Hospitalized Older Adults Before and After the Onset of the COVID-19 Pandemic · August 2023
Articles
JAMA Network Open
The Impacts of Clozapine Use on the Risk and Outcomes of COVID-19 Disease in Patients with Schizophrenia · May 2023
Articles
NCBI>Archives of Neuropsychiatry
Effect of Alteplase, Benzodiazepines and Beta-Blocker on Post-Stroke Pneumonia: Exploration of VISTA-Acute · May 2023
Articles
PLOS ONE
Physician Benzodiazepine Self-Use Prior to and During the COVID-19 Pandemic in Ontario, Canada: A Population-Level Cohort Study · April 2023
Articles
BMJ Open
“As Long as that Place Stays Open, I’ll Stay Alive”: Accessing Injectable Opioid Agonist Treatment during Dual Public Health Crises · April 2023
Articles
Harm Reduction Journal
Effects of Antidepressants on COVID-19 Outcomes: Retrospective Study on Large-Scale Electronic Health Record Data · April 2023
Articles
Interactive Journal of Medical Research
Repurposing Selective Serotonin Reuptake Inhibitors for Severity of COVID-19: A Population-Based Study · April 2023
Articles
European Neuropsychopharmacology
Overview of the Potential Use of Fluvoxamine for COVID-19 and Long COVID · March 2023
Articles
Discover Mental Health
Sales Trends of Psychotropic Drugs in the COVID-19 Pandemic: A National Database Study in Brazil · March 2023
Articles
Frontiers in Pharmacology
Changes in Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics (LAIs), Including Telepsychiatry Use, during the COVID-19 Pandemic · March 2023
Articles
Neuropsychiatric Disease and Treatment
Association between Use of Psychotropic Medications Prior to SARS-COV-2 Infection and Trajectories of COVID-19 Recovery: Findings from the Prospective Predi-COVID Cohort Study · March 2023
Articles
Frontiers in Public Health
Rates of Antipsychotic Drug Prescribing among People Living with Dementia during the COVID-19 Pandemic · January 2023
Abstracts
JAMA Psychiatry
Systematic Review and Meta-Analysis of the Efficacy of Benzodiazepines for Dyspnea in Patients with Cancer · January 2023
Articles
Japanese Journal of Clinical Oncology
Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial · January 2023
Multimedia (Interviews-Authors)
Journal of the American Medical Association
Neutropenia After the Coadministration of Clozapine and Nirmatrelvir-Ritonavir in a Patient with SARS-CoV-2 Infection: A Case Report with a Literature Review · December 2022
Articles
Frontiers in Psychiatry
Selective Serotonin Reuptake Inhibitors: New Hope in the Fight Against COVID-19 · November 2022
Articles
Frontiers in Pharmacology
Impact of Fluvoxamine on Outpatient Treatment of COVID-19 in Honduras in a Prospective Observational Real-World Study · November 2022
Articles
Frontiers in Pharmacology